bg
A

Arbutus Biopharma (ABUS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Arbutus Biopharma (ABUS)

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more

  • USD2.71
  • USD2.85
  • USD2.70
  • USD3.29
  • -7.20%
  • 24M
  • 683.61k
  • 926.18k
  • 492M
  • 1.69
  • 8.00%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.